This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Winthrop U.S.
Winthrop U.S., a prominent player in the pharmaceutical and biotechnology industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in the development and distribution of innovative healthcare solutions. With a strong operational presence across North America and Europe, Winthrop U.S. focuses on providing high-quality generic and specialty pharmaceuticals. The company’s core offerings include a diverse range of medications that cater to various therapeutic areas, setting them apart through rigorous quality standards and a commitment to affordability. Winthrop U.S. has achieved significant milestones, including numerous product launches and strategic partnerships, solidifying its market position as a trusted provider in the healthcare sector. With a dedication to improving patient outcomes, Winthrop U.S. continues to make strides in advancing accessible healthcare solutions.
DitchCarbon Score
How does Winthrop U.S.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Winthrop U.S.'s score of 93 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Winthrop U.S. currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. However, the company is a current subsidiary of Sanofi, and its climate commitments and initiatives are influenced by the parent organisation's sustainability strategies. Winthrop U.S. inherits its climate targets and performance metrics from Sanofi, which has established various reduction initiatives. These include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded down to Winthrop U.S. at a level 2 relationship. While specific reduction targets for Winthrop U.S. are not detailed, the overarching goals set by Sanofi reflect a commitment to reducing carbon emissions across its operations. As part of its climate strategy, Winthrop U.S. aligns with industry standards and best practices, although specific achievements or numerical targets have not been disclosed. The company is expected to contribute to the broader sustainability efforts of its parent organisation, focusing on reducing its carbon footprint and enhancing environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 545,114,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 677,549,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Winthrop U.S. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
